KINGDON CAPITAL MANAGEMENT, L.L.C. - Q3 2019 holdings

$847 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 61 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 58.7% .

 Value Shares↓ Weighting
MSFT SellMICROSOFT CORP$30,234,000
-21.8%
217,467
-24.6%
3.57%
-6.0%
ARMK SellARAMARK$26,382,000
+12.3%
605,371
-7.1%
3.12%
+35.0%
CSTM SellCONSTELLIUM SEcl a$26,274,000
+26.5%
2,067,180
-0.1%
3.10%
+52.0%
ERI SellELDORADO RESORTS INC$26,131,000
-22.3%
655,401
-10.3%
3.09%
-6.7%
QQQ SellINVESCO QQQ TRput$25,961,000
-46.5%
137,500
-47.1%
3.07%
-35.7%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$22,469,000
-11.6%
134,360
-10.4%
2.65%
+6.2%
IWM SellISHARES TRput$21,188,000
-84.2%
140,000
-83.8%
2.50%
-81.1%
ARGX SellARGENX SEsponsored adr$21,041,000
-29.4%
184,631
-12.2%
2.48%
-15.1%
AMZN SellAMAZON COM INC$17,081,000
-33.9%
9,840
-27.9%
2.02%
-20.5%
HUYA SellHUYA INC$15,265,000
-5.7%
645,738
-1.5%
1.80%
+13.3%
CP SellCANADIAN PAC RY LTD$15,147,000
-21.1%
68,088
-16.5%
1.79%
-5.1%
ZBRA SellZEBRA TECHNOLOGIES CORPcl a$13,287,000
-47.6%
64,382
-46.8%
1.57%
-37.1%
XBI SellSPDR SERIES TRUSTput$12,200,000
-65.2%
160,000
-60.0%
1.44%
-58.2%
WSC SellWILLSCOT CORP$11,394,000
-6.1%
731,300
-9.3%
1.35%
+12.9%
HRTX SellHERON THERAPEUTICS INC$9,356,000
-39.4%
505,729
-39.1%
1.10%
-27.2%
DIS SellDISNEY WALT CO$8,356,000
-37.6%
64,122
-33.1%
0.99%
-24.9%
SESN SellSESEN BIO INC$7,202,000
-22.1%
6,155,323
-0.2%
0.85%
-6.4%
ATNX SellATHENEX INC$6,525,000
-42.0%
536,373
-5.6%
0.77%
-30.2%
LSCC SellLATTICE SEMICONDUCTOR CORP$5,984,000
-38.6%
327,277
-51.0%
0.71%
-26.3%
MRNA ExitMODERNA INCput$0-10,700
-100.0%
-0.02%
DESTQ ExitDESTINATION MATERNITY CORP$0-174,816
-100.0%
-0.02%
DELL ExitDELL TECHNOLOGIES INCcl c$0-7,446
-100.0%
-0.04%
METC ExitRAMACO RES INC$0-276,246
-100.0%
-0.14%
AITB ExitAIT THERAPEUTICS INC$0-400,859
-100.0%
-0.22%
DCPH ExitDECIPHERA PHARMACEUTICALS INput$0-100,000
-100.0%
-0.22%
ARRY ExitARRAY BIOPHARMA INC$0-96,380
-100.0%
-0.44%
IQV ExitIQVIA HLDGS INC$0-28,121
-100.0%
-0.44%
ADPT ExitADAPTIVE BIOTECHNOLOGIES COR$0-115,000
-100.0%
-0.55%
OSW ExitONESPAWORLD HOLDINGS LIMITED$0-400,750
-100.0%
-0.61%
ATHM ExitAUTOHOME INCput$0-74,400
-100.0%
-0.63%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-296,346
-100.0%
-0.66%
LGFA ExitLIONS GATE ENTMNT CORPcl a vtg$0-551,836
-100.0%
-0.66%
MRVL ExitMARVELL TECHNOLOGY GROUP LTDord$0-308,200
-100.0%
-0.72%
AAL ExitAMERICAN AIRLS GROUP INC$0-238,428
-100.0%
-0.76%
CNC ExitCENTENE CORP DEL$0-186,583
-100.0%
-0.96%
RCL ExitROYAL CARIBBEAN CRUISES LTD$0-80,861
-100.0%
-0.96%
SAFM ExitSANDERSON FARMS INC$0-77,238
-100.0%
-1.04%
ZBH ExitZIMMER BIOMET HLDGS INC$0-93,731
-100.0%
-1.08%
UNH ExitUNITEDHEALTH GROUP INC$0-55,312
-100.0%
-1.33%
PFE ExitPFIZER INCput$0-315,400
-100.0%
-1.34%
BA ExitBOEING CO$0-50,890
-100.0%
-1.82%
NSC ExitNORFOLK SOUTHERN CORP$0-99,531
-100.0%
-1.95%
MIDD ExitMIDDLEBY CORP$0-152,259
-100.0%
-2.03%
COTY ExitCOTY INC$0-1,653,061
-100.0%
-2.18%
BSX ExitBOSTON SCIENTIFIC CORP$0-531,813
-100.0%
-2.25%
FCX ExitFREEPORT-MCMORAN INCcl b$0-3,140,882
-100.0%
-3.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q3 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (846588000.0 != 846589000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings